Your search returned 688 results.

Results
	81.	Maraviroc reduces viral load in naive patients at 48 weeks. [electronic resource] Producer: 20071105 In: AIDS patient care and STDs vol. 21 Availability: No items available. Save to lists Add to cart (remove)
	82.	Maraviroc: integration of a new antiretroviral drug class into clinical practice. [electronic resource] by Vandekerckhove, Linos Verhofstede, Chris Vogelaers, Dirk Producer: 20080619 In: The Journal of antimicrobial chemotherapy vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	83.	Treatment. Maraviroc dosing not effective in half of blacks. [electronic resource] Producer: 20141118 In: AIDS policy & law vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	84.	Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials. [electronic resource] by Lewis, Marilyn Mori, Julie Toma, Jonathan Mosley, Mike Huang, Wei Simpson, Paul Mansfield, Roy Craig, Charles van der Ryst, Elna Robertson, David L Whitcomb, Jeannette M Westby, Mike Producer: 20190424 In: PloS one vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	85.	Evaluation of Digital Image Recognition Methods for Mass Spectrometry Imaging Data Analysis. [electronic resource] by Ekelöf, Måns Garrard, Kenneth P Judd, Rika Rosen, Elias P Xie, De-Yu Kashuba, Angela D M Muddiman, David C Producer: 20190125 In: Journal of the American Society for Mass Spectrometry vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	86.	Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists. [electronic resource] by Poveda, Eva Alcamí, José Paredes, Roger Córdoba, Juan Gutiérrez, Félix Llibre, Josep María Delgado, Rafael Pulido, Federico Iribarren, José Antonio García Deltoro, Miguel Hernández Quero, José Moreno, Santiago García, Federico Producer: 20101104 In: AIDS reviews vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	87.	Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc. [electronic resource] by Delobel, Pierre Raymond, Stéphanie Mavigner, Maud Cazabat, Michelle Alvarez, Muriel Marchou, Bruno Massip, Patrice Izopet, Jacques Producer: 20101230 In: AIDS (London, England) vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	88.	Pharmacokinetics, safety and tolerability of a single oral dose of maraviroc in HIV-negative subjects with mild and moderate hepatic impairment. [electronic resource] by Abel, Samantha Davis, John D Ridgway, Caroline E Hamlin, Julia C Vourvahis, Manoli Producer: 20091211 In: Antiviral therapy vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	89.	Using density functional theory to rationalise the mass spectral fragmentation of maraviroc and its metabolites. [electronic resource] by Wright, Patricia Alex, Alexander Nyaruwata, Tsitsi Parsons, Teresa Pullen, Frank Producer: 20100621 In: Rapid communications in mass spectrometry : RCM vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	90.	Anti-HIV agents. New drugs--hope and a degree of caution. [electronic resource] Producer: 20071203 In: TreatmentUpdate vol. 19 Availability: No items available. Save to lists Add to cart (remove)
	91.	Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial). [electronic resource] by Soulié, Cathia Assoumou, Lambert Darty, Mélanie Rodriguez, Christophe Donati, Flora Sayon, Sophie Peytavin, Gilles Valantin, Marc-Antoine Caby, Fabienne Schneider, Luminita Canestri, Ana Costagliola, Dominique Katlama, Christine Calvez, Vincent Marcelin, Anne-Geneviève Producer: 20160826 In: The Journal of antimicrobial chemotherapy vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	92.	Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis. [electronic resource] by Huffman, Austin P Richman, Lee P Crisalli, Lisa Ganetsky, Alex Porter, David L Vonderheide, Robert H Reshef, Ran Producer: 20190305 In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	93.	Phenotypic co-receptor tropism and Maraviroc sensitivity in HIV-1 subtype C from East Africa. [electronic resource] by Siddik, Abu Bakar Haas, Alexandra Rahman, Md Shanawazur Aralaguppe, Shambhu Ganeshappa Amogne, Wondwossen Bader, Joelle Klimkait, Thomas Neogi, Ujjwal Producer: 20181211 In: Scientific reports vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	94.	Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients. [electronic resource] by Vandekerckhove, Linos Verhofstede, Chris Vogelaers, Dirk Producer: 20090630 In: The Journal of antimicrobial chemotherapy vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	95.	FDA approves maraviroc tablets. [electronic resource] Producer: 20071105 In: AIDS patient care and STDs vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	96.	Off-licence use of once-daily maraviroc in children and adolescents with perinatally acquired HIV-1 infection. [electronic resource] by Fraser-Taliente, T Mackie, N E Kaye, S Nyirenda, M Foster, C Producer: 20180820 In: HIV medicine vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	97.	Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies. [electronic resource] by Piotrowska, Anna Kwiatkowski, Klaudia Rojewska, Ewelina Makuch, Wioletta Mika, Joanna Producer: 20170718 In: Neuropharmacology vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	98.	A new class of anti-HIV therapy and new challenges. [electronic resource] by Dolin, Raphael Producer: 20081007 In: The New England journal of medicine vol. 359 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	99.	Maraviroc approved in the European Union. [electronic resource] Producer: 20071212 In: AIDS patient care and STDs vol. 21 Availability: No items available. Save to lists Add to cart (remove)
	100.	CCR5 antagonism in HIV infection: current concepts and future opportunities. [electronic resource] by Wilkin, Timothy J Gulick, Roy M Producer: 20120515 In: Annual review of medicine vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 688 results.